Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
Iskra Pusic, Catherine J. Lee, Muthu Veeraputhiran, Chelsea Minor, John F. DiPersio
Topics & Concepts
MedicineRuxolitinibGraft-versus-host diseaseRefractory (planetary science)Internal medicineHost (biology)OncologyImmunologyDiseaseMyelofibrosisBone marrowEcologyBiologyPhysicsAstrobiologyHematopoietic Stem Cell TransplantationMesenchymal stem cell researchChronic Myeloid Leukemia Treatments